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ABSTRACT 
Objective: The aim of this study was to investigate the antidiabetic activity of Javanese turmeric rhizome extract and its nanoparticles. Javanese 
turmeric rhizome contains curcumin, flavonoid, and xanthorrhizol that show the antidiabetic activity. The plant extracts entrapped within the 
nanoparticles have been reported to increase the active compound bioavailability. Thereby, the nanoparticles can improve the biological activity of 
active compounds.  
Methods: The rhizome was extracted by kinetic maceration using 96% (v/v) ethanol, whereas the nanoparticles were prepared by the ionic 
gelation method with different formulations to obtain two types of nanoparticles (F1 and F2). The resulting nanoparticles were evaluated for their 
particle size, zeta potential, and morphology. The antidiabetic study was performed in a model of alloxan-induced diabetic mice. The mice were 
divided into five groups, namely normal, negative, positive, extract (dose of 400 mg/kg) and nanoparticles group (dose of 400 mg/kg). Afterward, 
the blood glucose levels were observed within 24 d using a glucometer.  
Results: The nanoparticles F1 displayed particle size of 157.8±18.0 nm with a polydispersity index of 0.488 and zeta potential of+51.4±4.56 mV. 
Spray drying process of the suspension of nanoparticles F1 produced a fine yellow powder. In contrast, nanoparticles F2 assembled with a different 
solvent system gave rise to a smaller particles size (90±20.8 nm) but could not be dried. Hence, the nanoparticles F1 were further studied for the 
antidiabetic study. The results showed that the nanoparticles; F1 rendered a better antidiabetic activity compared to the extracts. Percentage of 
decrease in blood glucose levels of the extract and the nanoparticles were 39.62 and 47.52%, respectively.  
Conclusion: The type of solvent system of the extract could interfere with the resulting particle size of the nanoparticles. The nanoparticles could 
be promising carriers for the extract to improve the antidiabetic activity. 
Keywords: Javanese turmeric rhizome, Curcumin, Extract, Nanoparticles, Antidiabetic 
© 2020 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/) 
DOI: http://dx.doi.org/10.22159/ijap.2020v12i4.36249. Journal homepage: https://innovareacademics.in/journals/index.php/ijap  
 
INTRODUCTION 
Diabetes mellitus is the third leading cause of death in Indonesia 
with 6.7% after stroke and coronary heart disease. The number of 
diabetic patients also continues increasing and increasingly 
alarming. It was estimated that the number of diabetics patients will 
continue jumping, from 2.8% of the world’s population in 2000 to 
4.4% by 2030 [1, 2]. 
One of the methods that can be used to treat patients with diabetes 
mellitus is medicinal plants consumption. Many treatments use 
medicines from natural ingredients [3, 4]. One of the medicinal 
plants that have the efficacy as antidiabetic is turmeric rhizome that 
possesses many beneficial compounds. One of the compounds is 
curcumin. Several scientific studies have demonstrated the 
pharmacological potential of curcumin, including antioxidants, anti-
inflammatory, and antitumor. In addition, Javanese turmeric 
rhizome also contains xanthorrizol which is proven to lower blood 
glucose levels in alloxan-induced mice. This potential is related to 
hyperglycemia, which is one of the initial abnormal conditions of the 
homeostasis of blood glucose that can lead to the occurrence of 
diabetes mellitus of type 2 [5]. 
The extract of medicinal plants can be formulated into 
pharmaceutical dosage form through nanotechnologies. 
Furthermore, nanotechnology has been developed and applied to 
improve the permeation of the bioactive compounds of various 
extracts. The extract can be entrapped within the nanoparticles to 
improve their stability and bioavailability. Thereby, their biological 
activities could be optimized due to the increased blood level of the 
active compounds [6-8]. Therefore, it was the aim of the study to 
evaluate antidiabetic activity of Javanese turmeric rhizome extract 
entrapped within the nanoparticles in a model of alloxan-induced 
diabetic mice. Two different formulations of the nanoparticles were 
applied to the extract and their characterization was investigated.  
MATERIALS AND METHODS 
Materials 
Javanese turmeric rhizome, adult male mice (Mus musculus L.) DDY 
strain, chitosan (Biotech Surindo), dimethyl sulfoxide (DMSO), 
sodium tripolyphosphate (Na TPP) (Hubei Xingfa Chemical), 
propylene glycol, ethanol, capmul, alloxan tetrahydrate and 
glibenclamide (PT Indofarma, Indonesia). 
Methods 
Preparation of extract  
Javanese turmeric rhizome was identified by The Center for Plant 
Conservation Botanic Garden–Indonesian LIPI with the authentic 
number is B-112/IPH.3./KS/I/2018. The specimen was deposited in 
Herbarium of Pharmacognocy Laboratory, Faculty of Pharmacy, 
Pancasila University (1/DR/HLF/UP). The rhizomes were cleaned 
with water and dried in the dark. After drying, the rhizomes were 
powdered and extracted by maceration using 96% (v/v) ethanol as a 
solvent as described in the previous studies [9]. The mixture of 
maceration was then filtered. The filtrate was collected and 
concentrated by rotary vapor. Phytochemical screening was carried 
out to find out the secondary metabolic compounds in the extract [9]. 
Preparation of nanoparticles F1  
The ethanolic extract was dissolved in the mixture of solvent (20 ml 
propylene glycol, 20 ml 70% (v/v) ethanol, 20 ml 10% (v/v) DMSO 
and 100 ml distilled water). 1% (w/v) chitosan solution in glacial 
acetic acid was mixed with the extract solution in the final 
concentration of 0.2% (w/v). The mixture was stirred using a 
magnetic stirrer of 300 rpm for 10 min. afterward, 20 ml 0.4% (v/v) 
Na TPP solution was added dropwise at a rate of 1 drop/3 sec to the 
final mixture under permanent stirring of 300 rpm [10].  
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Preparation of nanoparticles F2 
Preparation of nanoparticle F2 was carried out as described previously 
with slightly modification. 1 g of chitosan was dissolved in 100 ml 1% 
(v/v) glacial acetic acid using a magnetic stirrer to obtain a concentration 
of 1% (w/v). A total of 500 mg of Javanese turmeric rhizome extract was 
added to the mixture consisting of 5 ml capmul, 10 ml 70% (v/v) 
ethanol, 10 ml propylene glycol, 5 ml glycerin, 5 ml tween 80, and 5 ml 
distilled water. Afterwards, 5 ml 1% (w/v) chitosan solution was added 
to the extract solution to obtain a concentration of 0.1% (w/v). The final 
mixture was stirred using a magnetic stirrer for 10 min. 5 ml 0.2% (w/v) 
Na-TPP were added dropwise to the final mixture at a rate of 1 drop/3 s 
under a permanent stirring of 300 rpm to form nanoparticles with 
homogeneous turbidity [9].  
Evaluation of nanoparticles  
Particle size and zeta potential value of the resulting nanoparticles was 
determined by particle and zeta sizer, while the morphologies study was 
carried out by transmission electron microscopy (TEM) and scanning 
electron microscopy (SEM). 1 ml the nanoparticles were diluted with 99 
ml distilled water before all the evaluations. The suspension of 
nanoparticles was observed for its stability within 5 d, including color, 
turbidity and sedimentation. The stable nanosuspension was then dried 
using a spray dryer at an inlet temperature of 185 and 195 °C. The dried 
powder was used for the morphology study using SEM and antidiabetic 
activity evaluation [9, 10].  
Antidiabetic activity study 
Antidiabetic activity study used male mice DDY strains (3-4 w old) 
with weights ranging from 21 to 26 g (mean weight of 23 g). The mice 
were bred in the animal house at Laboratory of Non-Ruminansia and 
Hope Animal, Faculty of Animal Husbandry, Bogor Agricultural 
University, Indonesia. The mice were acclimatized for 7 d to laboratory 
conditions (25±2 °C) with 12 h/12 h darkness photoperiod at Faculty 
of Pharmacy, Pancasila University, Indonesia. The mice were kept in 
cages (5 mice per cage randomly) and had free access to standard 
pellet and water. The experimental protocols and procedures used in 
this study were approved by the Ethics Committee for Health Research 
(no: KET-929/UN2. F1/ETIK/PPM.00.02/2019) of Medical Faculty of 
Universitas Indonesia, Indonesia. Afterward, the mice were measured 
for blood glucose levels before and after alloxan administration 
(hyperglycemia condition) at the dose of 200 mg/kg body weight 
intraperitoneally for 3 d, and after the treatment (d 0, d 10, d 17 and d 
24), the blood glucose levels of the mice measured by blood sampling 
from the tail vein of the mice were determined using a glucometer.  
All mice were divided into 5 groups and each group consisted of 5 
mice which were taken randomly and treated as follows: group 1 as 
normal control without any treatment; group 2 as positive control 
treated with glibenclamide at the dose of 0.52 mg/20 g body weight; 
group 3 as a negative control treated with distilled water using the 
alloxan-induced diabetic mice; group 4 treated with the extract at 
the dose of 400 mg/kg body weight; and group 5 treated with the 
nanoparticles at the dose of 400 mg/kg body weight [11, 12]. 
Statistical analysis 
The results that met the requirements were then processed by the 
statistical analysis method of one-way variation (ANOVA). The 
obtained significant difference was further analyzed using the Mann-
Whitney test. 
RESULTS AND DISCUSSION 
Preparation of extract  
The extract was viscous with rendement as reported previously and 
could harden in the storage at the temperature of 4 °C. 
Phytochemical screening was performed to determine the secondary 
metabolite in the simplicia powder and in the extract. The results 
indicated that the powder and the extract contained flavonoid, 
saponin, steroid/triterpenoid and essential oil [9].  
Preparation of nanoparticles F1 
The extract was soluble in the mixture of propylene glycol, ethanol 
and DMSO. The ratio of each solvent resulted in dielectric constant 
value, which could break the extract into molecules of the 
compounds. The extract was even more soluble in the presence of a 
chitosan solution. After adding Na TPP solution, the color of the final 
solution changed due to the nanoparticles formation.  
Preparation of nanoparticles F2  
Capmul, glycerin and tween 80 could be used to replace DMSO for 
solubilization of the extract. Capmul is mono-diglyceride, which is an 
excellent solvent for organic compounds, including the extract. In 
addition, tween 80 and glycerine are capable of dissolving the non-
polar substances in the extract, which could render the formation of 
small particles. The extract solution of F2 was more viscous than 
that of F1. Hence, it could inhibit the interaction between the 
chitosan solution and Na TPP solution. There was no significant 
change in color of the mixture of extract solution of F2 and the 
chitosan solution after the addition of Na TPP solution.  
Evaluation of nanoparticles  
The nanoparticles F1 and F2 were stable within 5 d and were 
evaluated for their particle size and zeta potential. The results are 
shown in table 1. 
 
Table 1: Characterization of the nanoparticles F1 and F2 
Parameters F1 F2* * 
Particle Size (nm) 
Polydipersity index 









Data represented as mean±SD (n=3) 
The nanoparticles F1 and F2 demonstrated 157.8 and 93.9 nm in 
particle size, respectively indicating that the extract was entrapped 
within the nanoparticles with the particle size in nano scale. The 
particle size of F1 was bigger than that of F2 due the difference in 
the used solvents. The mixture of capmul, tween 80 and glycerine 
was able to solubilize the multicomponents of extract and resulted 
in the viscous solution of extract. Thereby, the nanoparticles F2 was 
slowly formed. In addition, as an excellent solvent, capmul could 
break the big particles formed when the drops of Na TPP solution 
were added to the mixture of extract and chitosan solution.  
A zeta potential measurements can predict the storage stability of 
colloidal dispersions. In general, particles aggregation are less likely to 
occur in charged particles (having high zeta potential) due to electrical 
repulsion. Generally, zeta potential values above 30 mV (both positive 
and negative) will form a more stable nanoparticles suspension 
because the repulsion between particles prevents aggregation [9]. In 
contrast, low zeta potential can cause the aggregation of particles. The 
charges on the surface of the nanoparticles will affect its distribution in 
the body and influence the uptake of nanoparticles into the cells. The 
cell membranes have negative charges, therefore, the positively 
charged nanoparticles will have a stronger electrostatic affinity [9]. 
The result showed that the nanoparticle F1 and F2 exhibited zeta 
potential of+51.4 and-0.55 mV, respectively. The nanoparticles F1 
could be more stable in aqueous medium compared to the 
nanoparticles F2, which could not be dried using spray dryer. Thereby, 
the nanoparticles F1 was used for further studies.  
After drying, the nanoparticles F1 had a water content of 9.47% and 
a yellow color. The results of the morphological evaluation of 
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nanoparticle suspension using TEM and SEM can be seen in fig. 1 
and 3, respectively. Polymer-based drug delivery systems takes a 
chance in many ways for improving the efficacy of active 
compounds. The biodegradable polymers have the advantage of 
their metabolites elimination by genuine metabolic processes [12]. 
 
 
Fig. 1: Morphology of the nanoparticle F1 using TEM 
 
 
Fig. 2: Morphology of the nanoparticle F2 using TEM 
 
Antidiabetic study 
There was a weight loss in all groups except the normal group on 
day 10 in hyperglycemic conditions. This is because the need of 
energy could not be fulfilled by glucose metabolism of the body. This 
condition could be caused by damage in pancreatic β cells due to 
alloxan administration. Number of studies showed that alloxan 
administration in mice can increase blood glucose levels [13]. After 
being given treatment for 14 d, positive control, extract and the 
nanoparticles F1 were able to increase insulin secretion, to improve 
insulin receptor sensitivity and to repair the damage of pancreatic β 
cells, thus decrease the blood glucose level. The other studies 
showed that the extract of medicinal plant treated rats displayed a 
significant decrease in the lipid content when compared with 
diabetic induced rats [14, 15].  
To determine the effectiveness of treatment on mice, the 
percentages of decrease in blood glucose level in mice treated after 7 
d (17 d) and 14 d (24 d) were calculated. The percentage of decrease 
in blood glucose levels can be seen in table 2. 
 
 




Fig. 4: Blood glucose levels before and after the treatment 
(*
 
Data represented as mean±SD, n=5) 
Table 2: The percentage of decrease in blood glucose levels of mice after the treatment 
Group The percentage decrease (%) 
D 17* D 24  *  
Normal control 3.12±4.04 3.31±3.03 
Negative control 2.05±0.49 4.92±4.45 
Positive control 38.49±4.02 48.95±5,31 
Extract 25.61±1.53 39.62±2,31 
The nanoparticles F1 30.75±1.34  47.52±6.03 
Notes: *
 
Data represented as mean±SD (n=3) 
During the 7 d of treatment (day 10) there was a decrease in blood 
glucose levels of mice in three groups, positive control, extract, and 
the nanoparticles F1 as depicted in fig. 4. It can be seen that 
glibenclamide (positive control) can decrease blood glucose levels of 
the hyperglycemia mice by 38.49% while extract and the 
nanoparticles F1 25.61% and 30.75%, respectively. 
After 14 d, the decrease of the blood glucose level of the mice was 
comparatively high in the positive control (48.95%), extract (39.62%), 
and the nanoparticles F1 (47.52%). Based on the results of statistical 
tests, there was a significant difference between extract and the 
nanoparticles F1 so that it can be assumed that the nanoparticles F1 
had the ability to lower blood glucose levels of mice better than the 
activity of the extract. The nanoparticles F1 could reach the organ 
target, whereas chitosan in the nanoparticles F1 could protect the 
active compounds against the degradation in the body and has 
mucoadhesive properties [10]. The results of this study indicate that 
the nanoparticles prepared with Na TPP-chitosan carrier had better 
antidiabetic activity compared to the extract. These results showed the 
similarities with previous studies that compared the antidiabetic 
activity of catharantus roseus extract and nanoparticles containing 
catharantus roseus extract [11]. The nanosystem, such as liposomes, 
microemulsion, and the other nanoparticles, is used to improve oral 
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drug delivery. The nanoparticles have been used to enhance the 
permeation of glucose and to prolong the action of active compounds. 
Many studies have been demonstrated how to encapsulate the drugs 
into an encapsulation system to enhance the bioavailability 
subsequently showed better relative pharmacological efficacy [16]. 
CONCLUSION 
The nanoparticles with a dose of 400 mg extract/kg body weight 
showed higher activity in lowering the blood glucose levels in the 
alloxan-induced diabetic mice compared to the extract. Therefore, 
the nanoparticles seems to be a promising strategy to deliver the 
extract to the target organ. 
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